The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Hormonal Transdermal Patches-Global Market Insights and Sales Trends 2024
Synopsis
The global Hormonal Transdermal Patches market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hormonal Transdermal Patches in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Hormonal Transdermal Patches market. Contraceptive Patches, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Estradiol Patches segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Hormonal Transdermal Patches market, driven by demand from China, the second largest economy with some signs of stabilising, the Hormonal Transdermal Patches market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hormonal Transdermal Patches, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hormonal Transdermal Patches market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hormonal Transdermal Patches market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hormonal Transdermal Patches sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hormonal Transdermal Patches covered in this report include Xulane, Twirla, Planned Parenthood, Lvye Pharma, Novartis, Bayer Healthcare Pharmaceuticals, Watson Labs, Women First Healthcare Inc and Noven, etc.
The global Hormonal Transdermal Patches market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Xulane
Twirla
Planned Parenthood
Lvye Pharma
Novartis
Bayer Healthcare Pharmaceuticals
Watson Labs
Women First Healthcare Inc
Noven
AbbVie
Lumara Health
ANI Pharmaceuticals
Global Hormonal Transdermal Patches market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hormonal Transdermal Patches market, Segment by Type:
Contraceptive Patches
Estradiol Patches
Others
Global Hormonal Transdermal Patches market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hormonal Transdermal Patches manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hormonal Transdermal Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Hormonal Transdermal Patches market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hormonal Transdermal Patches in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Hormonal Transdermal Patches market. Contraceptive Patches, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Estradiol Patches segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Hormonal Transdermal Patches market, driven by demand from China, the second largest economy with some signs of stabilising, the Hormonal Transdermal Patches market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hormonal Transdermal Patches, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hormonal Transdermal Patches market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hormonal Transdermal Patches market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hormonal Transdermal Patches sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hormonal Transdermal Patches covered in this report include Xulane, Twirla, Planned Parenthood, Lvye Pharma, Novartis, Bayer Healthcare Pharmaceuticals, Watson Labs, Women First Healthcare Inc and Noven, etc.
The global Hormonal Transdermal Patches market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Xulane
Twirla
Planned Parenthood
Lvye Pharma
Novartis
Bayer Healthcare Pharmaceuticals
Watson Labs
Women First Healthcare Inc
Noven
AbbVie
Lumara Health
ANI Pharmaceuticals
Global Hormonal Transdermal Patches market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hormonal Transdermal Patches market, Segment by Type:
Contraceptive Patches
Estradiol Patches
Others
Global Hormonal Transdermal Patches market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hormonal Transdermal Patches manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hormonal Transdermal Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Hormonal Transdermal Patches Market Overview
1.1 Hormonal Transdermal Patches Product Overview
1.2 Hormonal Transdermal Patches Market Segment by Type
1.2.1 Contraceptive Patches
1.2.2 Estradiol Patches
1.2.3 Others
1.3 Global Hormonal Transdermal Patches Market Size by Type
1.3.1 Global Hormonal Transdermal Patches Market Size Overview by Type (2018-2029)
1.3.2 Global Hormonal Transdermal Patches Historic Market Size Review by Type (2018-2023)
1.3.3 Global Hormonal Transdermal Patches Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hormonal Transdermal Patches Sales Breakdown by Type (2018-2023)
1.4.2 Europe Hormonal Transdermal Patches Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Hormonal Transdermal Patches Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Hormonal Transdermal Patches Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Hormonal Transdermal Patches Sales Breakdown by Type (2018-2023)
2 Global Hormonal Transdermal Patches Market Competition by Company
2.1 Global Top Players by Hormonal Transdermal Patches Sales (2018-2023)
2.2 Global Top Players by Hormonal Transdermal Patches Revenue (2018-2023)
2.3 Global Top Players by Hormonal Transdermal Patches Price (2018-2023)
2.4 Global Top Manufacturers Hormonal Transdermal Patches Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hormonal Transdermal Patches Market Competitive Situation and Trends
2.5.1 Hormonal Transdermal Patches Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Hormonal Transdermal Patches Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hormonal Transdermal Patches as of 2022)
2.7 Date of Key Manufacturers Enter into Hormonal Transdermal Patches Market
2.8 Key Manufacturers Hormonal Transdermal Patches Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hormonal Transdermal Patches Status and Outlook by Region
3.1 Global Hormonal Transdermal Patches Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hormonal Transdermal Patches Historic Market Size by Region
3.2.1 Global Hormonal Transdermal Patches Sales in Volume by Region (2018-2023)
3.2.2 Global Hormonal Transdermal Patches Sales in Value by Region (2018-2023)
3.2.3 Global Hormonal Transdermal Patches Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Hormonal Transdermal Patches Forecasted Market Size by Region
3.3.1 Global Hormonal Transdermal Patches Sales in Volume by Region (2024-2029)
3.3.2 Global Hormonal Transdermal Patches Sales in Value by Region (2024-2029)
3.3.3 Global Hormonal Transdermal Patches Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hormonal Transdermal Patches by Application
4.1 Hormonal Transdermal Patches Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Hormonal Transdermal Patches Market Size by Application
4.2.1 Global Hormonal Transdermal Patches Market Size Overview by Application (2018-2029)
4.2.2 Global Hormonal Transdermal Patches Historic Market Size Review by Application (2018-2023)
4.2.3 Global Hormonal Transdermal Patches Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hormonal Transdermal Patches Sales Breakdown by Application (2018-2023)
4.3.2 Europe Hormonal Transdermal Patches Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Hormonal Transdermal Patches Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Hormonal Transdermal Patches Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Hormonal Transdermal Patches Sales Breakdown by Application (2018-2023)
5 North America Hormonal Transdermal Patches by Country
5.1 North America Hormonal Transdermal Patches Historic Market Size by Country
5.1.1 North America Hormonal Transdermal Patches Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hormonal Transdermal Patches Sales in Volume by Country (2018-2023)
5.1.3 North America Hormonal Transdermal Patches Sales in Value by Country (2018-2023)
5.2 North America Hormonal Transdermal Patches Forecasted Market Size by Country
5.2.1 North America Hormonal Transdermal Patches Sales in Volume by Country (2024-2029)
5.2.2 North America Hormonal Transdermal Patches Sales in Value by Country (2024-2029)
6 Europe Hormonal Transdermal Patches by Country
6.1 Europe Hormonal Transdermal Patches Historic Market Size by Country
6.1.1 Europe Hormonal Transdermal Patches Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hormonal Transdermal Patches Sales in Volume by Country (2018-2023)
6.1.3 Europe Hormonal Transdermal Patches Sales in Value by Country (2018-2023)
6.2 Europe Hormonal Transdermal Patches Forecasted Market Size by Country
6.2.1 Europe Hormonal Transdermal Patches Sales in Volume by Country (2024-2029)
6.2.2 Europe Hormonal Transdermal Patches Sales in Value by Country (2024-2029)
7 Asia-Pacific Hormonal Transdermal Patches by Region
7.1 Asia-Pacific Hormonal Transdermal Patches Historic Market Size by Region
7.1.1 Asia-Pacific Hormonal Transdermal Patches Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hormonal Transdermal Patches Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Hormonal Transdermal Patches Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Hormonal Transdermal Patches Forecasted Market Size by Region
7.2.1 Asia-Pacific Hormonal Transdermal Patches Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hormonal Transdermal Patches Sales in Value by Region (2024-2029)
8 Latin America Hormonal Transdermal Patches by Country
8.1 Latin America Hormonal Transdermal Patches Historic Market Size by Country
8.1.1 Latin America Hormonal Transdermal Patches Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hormonal Transdermal Patches Sales in Volume by Country (2018-2023)
8.1.3 Latin America Hormonal Transdermal Patches Sales in Value by Country (2018-2023)
8.2 Latin America Hormonal Transdermal Patches Forecasted Market Size by Country
8.2.1 Latin America Hormonal Transdermal Patches Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hormonal Transdermal Patches Sales in Value by Country (2024-2029)
9 Middle East and Africa Hormonal Transdermal Patches by Country
9.1 Middle East and Africa Hormonal Transdermal Patches Historic Market Size by Country
9.1.1 Middle East and Africa Hormonal Transdermal Patches Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hormonal Transdermal Patches Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Hormonal Transdermal Patches Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Hormonal Transdermal Patches Forecasted Market Size by Country
9.2.1 Middle East and Africa Hormonal Transdermal Patches Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hormonal Transdermal Patches Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Xulane
10.1.1 Xulane Company Information
10.1.2 Xulane Introduction and Business Overview
10.1.3 Xulane Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Xulane Hormonal Transdermal Patches Products Offered
10.1.5 Xulane Recent Development
10.2 Twirla
10.2.1 Twirla Company Information
10.2.2 Twirla Introduction and Business Overview
10.2.3 Twirla Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Twirla Hormonal Transdermal Patches Products Offered
10.2.5 Twirla Recent Development
10.3 Planned Parenthood
10.3.1 Planned Parenthood Company Information
10.3.2 Planned Parenthood Introduction and Business Overview
10.3.3 Planned Parenthood Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Planned Parenthood Hormonal Transdermal Patches Products Offered
10.3.5 Planned Parenthood Recent Development
10.4 Lvye Pharma
10.4.1 Lvye Pharma Company Information
10.4.2 Lvye Pharma Introduction and Business Overview
10.4.3 Lvye Pharma Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Lvye Pharma Hormonal Transdermal Patches Products Offered
10.4.5 Lvye Pharma Recent Development
10.5 Novartis
10.5.1 Novartis Company Information
10.5.2 Novartis Introduction and Business Overview
10.5.3 Novartis Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Novartis Hormonal Transdermal Patches Products Offered
10.5.5 Novartis Recent Development
10.6 Bayer Healthcare Pharmaceuticals
10.6.1 Bayer Healthcare Pharmaceuticals Company Information
10.6.2 Bayer Healthcare Pharmaceuticals Introduction and Business Overview
10.6.3 Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Products Offered
10.6.5 Bayer Healthcare Pharmaceuticals Recent Development
10.7 Watson Labs
10.7.1 Watson Labs Company Information
10.7.2 Watson Labs Introduction and Business Overview
10.7.3 Watson Labs Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Watson Labs Hormonal Transdermal Patches Products Offered
10.7.5 Watson Labs Recent Development
10.8 Women First Healthcare Inc
10.8.1 Women First Healthcare Inc Company Information
10.8.2 Women First Healthcare Inc Introduction and Business Overview
10.8.3 Women First Healthcare Inc Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Women First Healthcare Inc Hormonal Transdermal Patches Products Offered
10.8.5 Women First Healthcare Inc Recent Development
10.9 Noven
10.9.1 Noven Company Information
10.9.2 Noven Introduction and Business Overview
10.9.3 Noven Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Noven Hormonal Transdermal Patches Products Offered
10.9.5 Noven Recent Development
10.10 AbbVie
10.10.1 AbbVie Company Information
10.10.2 AbbVie Introduction and Business Overview
10.10.3 AbbVie Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2018-2023)
10.10.4 AbbVie Hormonal Transdermal Patches Products Offered
10.10.5 AbbVie Recent Development
10.11 Lumara Health
10.11.1 Lumara Health Company Information
10.11.2 Lumara Health Introduction and Business Overview
10.11.3 Lumara Health Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Lumara Health Hormonal Transdermal Patches Products Offered
10.11.5 Lumara Health Recent Development
10.12 ANI Pharmaceuticals
10.12.1 ANI Pharmaceuticals Company Information
10.12.2 ANI Pharmaceuticals Introduction and Business Overview
10.12.3 ANI Pharmaceuticals Hormonal Transdermal Patches Sales, Revenue and Gross Margin (2018-2023)
10.12.4 ANI Pharmaceuticals Hormonal Transdermal Patches Products Offered
10.12.5 ANI Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hormonal Transdermal Patches Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hormonal Transdermal Patches Industrial Chain Analysis
11.4 Hormonal Transdermal Patches Market Dynamics
11.4.1 Hormonal Transdermal Patches Industry Trends
11.4.2 Hormonal Transdermal Patches Market Drivers
11.4.3 Hormonal Transdermal Patches Market Challenges
11.4.4 Hormonal Transdermal Patches Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hormonal Transdermal Patches Distributors
12.3 Hormonal Transdermal Patches Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
